Melky Cabrera signed a two-year, $16 million contract with the Blue Jays, which seems pretty good given that he hasn’t played since getting slapped with a 50-game PED suspension and then got kicked to the curb by the Giants when he was eligible to return in the postseason.
Still, it’s a two-year deal at a fraction of what he figured to get previously. Even if he slumped some during the final month and a half and into the postseason, he was likely looking at something in the neighborhood of $50 million for four years as a free agent this winter. A strong finish could have netted him $70 million for five years.
So why lock into that extra year? Cabrera was no second-year guy needing financial security in the form of a long-term deal; he’s already earned about $11 million in his career. He could afford to gamble if he were confident in his ability to bounce back and put together a strong 2013 season. We may never know whether the Jays would have signed him to a one-year, $8 million deal if that’s what he preferred — they may have wanted that extra upside the second year provides — but it’s hard to imagine they or someone else wouldn’t have given him at least $6 million for 2013 alone.
It suggests to me that Cabrera doesn’t see himself coming back and having another season like his 2012. Because if he did, he would have taken the one-year deal and then chased the big payday.
Maybe I’m wrong. And I don’t want this to read as a condemnation of Cabrera. But it’s intriguing to me. I think of most athletes as supremely confident in their abilities on the field (or the court, track, rink, etc.). And while Melky took his game to a whole new level in 2012, he was also something much more than an $8 million player with the Royals in 2011. If he isn’t confident he can get back to that — if he doesn’t think of himself as being worth $15 million per year or what have you — then I’m not all that sure I’d want to sign him at any price.
Former Tigers infielder Casey McGehee has reportedly signed a one-year deal with the Yomiuri Giants of Nippon Professional Baseball, according to FOX Sports’ Ken Rosenthal.
It’s the fourth move the corner infielder has made in the last two seasons after seeing short-term stints with the Marlins, Giants and Tigers. He signed a minor league deal with the Tigers prior to the 2016 season, providing the club with some infield depth behind 24-year-old Nick Castellanos. When Castellanos hit the disabled list in August with a broken hand, McGehee was recalled from Triple-A Toledo for a 30-game stint and slashed .228/.260/.239 with one extra-base hit in 96 PA. His career batting line (.258/.317/.384 over eight seasons) isn’t too shabby, but his age and a long history of knee injuries puts a damper on his potential.
McGehee last appeared in the NPB circuit in 2013, when he signed a one-year, $1.5 million deal with the Tohoku Rakuten Golden Eagles. He spent the bulk of his season at the hot corner, batting an impressive .292/.396/.515 with 28 homers in 590 PA and appearing in the Eagles’ first and only championship run to date.
The deal comes with a club option for 2018, Rosenthal reports, though no figure has been specified.
Free agent left-hander Rich Hill is rumored to be entertaining a three-year, $40+ million offer from the Dodgers, reports Peter Gammons. The Boston Globe’s Nick Cafardo corroborated the report, adding that Hill could receive somewhere between $46 and $48 million from his former team.
Hill, 36, pitched to a 2.12 ERA and 3.91 FIP in back-to-back stints with the Athletics and Dodgers in 2016. While a chronic case of blisters on his pitching hand limited the frequency of his starts, he still figures to be one of the most productive and noteworthy starting pitchers on the market this winter.
The Orioles, Yankees, Red Sox, Rangers and Astros have all been mentioned as potential suitors for the left-hander’s services, though Orioles’ GM Dan Duquette said the club has yet to make a play for Hill and ESPN’s Jim Bowden pointed out that the Red Sox are less involved in trade talks than other interested parties.